Mandate

Vinge assists NAXS in connection with change of listing to NASDAQ OMX Stockholm

June 01, 2010

NAXS Nordic Access Buyout Fund AB (publ) commenced operations in 2007 and is a company investing in buyout funds with a Nordic focus. The objective is to make the Nordic private equity market accessible to a broader range of investors, which are also offered liquidity through NAXS’s listed shares. The shares have been listed on NASDAQ OMX First North since May 2007 and the admittance to trading of the NAXS share on NASDAQ OMX Stockholm has now been approved by the NASDAQ OMX Stockholm’s Listing Committee. The first day of trading for NAXS’s shares on NASDAQ OMX Stockholm is expected to be Monday, 7 June 2010 and the last day of trading on NASDAQ OMX First North is expected to be Friday, 4 June 2010.

Vinge’s team has primarily consisted of Göran Nyström, Jesper Schönbeck and Emil Hedberg.

Related

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025

Vinge advises Karl Hedin and minority owners on the sale of AB Karl Hedin Sågverk to Vida

Vinge has advised Karl Hedin and minority shareholders in connection with the sale of AB Karl Hedin Sågverk to Vida Aktiebolag (“Vida”).
July 24, 2025